Eileen S. Carpenter, MD, PhD
A gastroenterologist and clinician-scientist working on benign and malignant diseases of the pancreas — taking biopsies in clinic and reading them at single-cell resolution in the lab.
Overview
Dr. Eileen S. Carpenter is a gastroenterologist and clinician-scientist whose clinical focus is benign and malignant diseases of the pancreas. She holds a joint appointment with the University of Michigan and the VA Ann Arbor Healthcare System, and sits on the Pancreatic Cancer Clinic team at the Rogel Cancer Center.
Research
Her lab develops pipelines using endoscopic fine needle biopsies of pancreatic tumors, applying single-cell RNA sequencing, mass cytometry and organoid culture to study tumor heterogeneity, chemoresistance and immunotherapy targets. That includes longitudinal matched biopsies taken before and after chemotherapy to identify resistance mechanisms, and tracking how the immune and stromal microenvironment shifts over time.
Training
A bachelor’s in chemical engineering from The Cooper Union, then an MD/PhD through the Medical Scientist Training Program at SUNY Stony Brook, followed by internal medicine residency and a gastroenterology fellowship at the University of Michigan — both on the fast-track research pathway.
Nine physicians, researchers and staff who decide what Sky funds.
Back to the SAC →Eileen S. Carpenter, MD, PhD
A gastroenterologist and clinician-scientist working on benign and malignant diseases of the pancreas — taking biopsies in clinic and reading them at single-cell resolution in the lab.
Overview
Dr. Eileen S. Carpenter is a gastroenterologist and clinician-scientist whose clinical focus is benign and malignant diseases of the pancreas. She holds a joint appointment with the University of Michigan and the VA Ann Arbor Healthcare System, and sits on the Pancreatic Cancer Clinic team at the Rogel Cancer Center.
Research
Her lab develops pipelines using endoscopic fine needle biopsies of pancreatic tumors, applying single-cell RNA sequencing, mass cytometry and organoid culture to study tumor heterogeneity, chemoresistance and immunotherapy targets. That includes longitudinal matched biopsies taken before and after chemotherapy to identify resistance mechanisms, and tracking how the immune and stromal microenvironment shifts over time.
Training
A bachelor’s in chemical engineering from The Cooper Union, then an MD/PhD through the Medical Scientist Training Program at SUNY Stony Brook, followed by internal medicine residency and a gastroenterology fellowship at the University of Michigan — both on the fast-track research pathway.
Nine physicians, researchers and staff who decide what Sky funds.
Back to the SAC →